High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population

Clinical Chemistry

Volumn 57, Issue 8, 2011, Pages 1146-1153

  Kavsak, Peter A ^a   Xu, Liqin ^b   Yusuf, Salim ^b,c   McQueen, Matthew J ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; STROKE;

AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; ROC CURVE; STROKE; TROPONIN I;

EID: 79961050437     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.164574     Document Type: Article

References (37)

1. Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 2006;152:118-25. (Pubitemid 44026455)
2. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
3. Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS. Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients. Clin Chem 2006;52: 2028-35. (Pubitemid 44658203)
4. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007;116:1907-14. (Pubitemid 350287086)
5. Eggers KM, Lagerqvist B, Oldgren J, Venge P, Wallentin L, Lindahl B. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Am Heart J 2008;156:85-92.
6. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, Jarolim P, Braunwald E, Morrow DA. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010;55:2118-24.
7. Lindahl B, Venge P, James S. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J 2010;160:224-9.
8. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006;113:1071-8.
9. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem 2007;53: 220-7. (Pubitemid 46343361)
10. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the Centaur TnI-ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54:723-8. (Pubitemid 351573705)
11. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-47.
12. deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-502.
13. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
14. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
15. Jaffe AS, Apple FS. High-sensitivity cardiac troponin: hype, help, and reality. Clin Chem 2010; 56:342-4.
16. Wu A, Collinson P, Jaffe A, Morrow D. High-sensitivity cardiac troponin assays: what analytical and clinical issues need to be addressed before introduction into clinical practice? Interview by Fred S. Apple. Clin Chem 2010;56:886-91.
17. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Clin Chem 2010;56:941-3.
18. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
19. Wu AH, Fukushima N, Puskas R, Todd J, Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006;52:2157-9.
20. Wu AH, Agee SJ, Lu QA, Todd J, Jaffe AS. Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology. Clin Chem 2009;55:196-8.
21. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009; 55:573-7.
22. Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. Am Heart J 2009;158:386-91.
23. Apple FS, Simpson PA, Murakami MM. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin Biochem 2010;43:1034-6.
24. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54: 1165-72.
25. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009; 55:1809-15.
26. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
27. Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 2006;114: 201-8. (Pubitemid 44297113)
28. Kavsak PA, McQueen MJ. Sensitive and high sensitivity cardiac troponin I concentrations in the Heart Outcomes Prevention Evaluation (HOPE) study: a high risk population. Clin Chim Acta 2010;411:1832.
29. Kavsak PA. Highly sensitive cardiac troponin T assay, cardiac disease, and mortality risk. JAMA 2011;305:1196.
30. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358: 2107-16. (Pubitemid 351679597)
31. Kavsak PA, McQueen MJ. High sensitivity cardiac troponin concentration cutoffs: is a healthy population the right reference population for those with underlying cardiac disease? Clin Biochem 2010;43:1037-8.
32. Schulz O, Reinicke M, Berghoefer GH, Bensch R, Kraemer J, Schimke I, Jaffe AS. High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray. Clin Chim Acta 2010;411:812-7.
33. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009; 55:52-8.
34. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-90.
35. Kavsak PA, Ko DT, Wang X, MacRae AR, Jaffe AS. 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin assay. Clin Chem 2010;56:487-9.
36. Kavsak PA, Ko DT, Wang X, MacRae AR, Jaffe AS. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs. percentage changes and long-term outcomes in a chest pain cohort. Clin Chem 2010; 56:1905-7.
37. Apple FS. High-sensitivity cardiac troponin for screening large populations of healthy people: is there risk? Clin Chem 2011;57:537-9.